{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:51:49Z","timestamp":1791219109434,"version":"4.1.0"},"reference-count":67,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2024]]},"DOI":"10.3960\/jslrt.24031","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T22:31:43Z","timestamp":1727476303000},"page":"156-165","source":"Crossref","is-referenced-by-count":19,"title":["Histiocytic neoplasms: a brief review and differential diagnosis"],"prefix":"10.3960","volume":"64","author":[{"given":"Rin","family":"Yamada","sequence":"first","affiliation":[{"name":"Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Komohara","sequence":"additional","affiliation":[{"name":"Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Chan J, Alaggio R, Coupland SE. Histiocytic\/dendritic cell neoplasms: Introduction. In: WHO Classification of Tumours Editorial Board (eds): Haematolymphoid Tumours, WHO Classification of Tumours Series, 5th ed, vol. 11 [Internet]. Lyon, International Agency for Research on Cancer. 2024 [cited 2024 Jun 10]. Available from: https:\/\/tumourclassification.iarc.who.int\/chapters\/63."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Kemps PG, Kester L, Scheijde-Vermeulen MA et al.<\/i> Demographics and additional haematologic cancers of patients with histiocytic\/dendritic cell neoplasms. Histopathology. 2024; 84: 837-846.","DOI":"10.1111\/his.15127"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Janssen D, Harms D. Juvenile xanthogranuloma in childhood and adolescence: a clinicopathologic study of 129 patients from the kiel pediatric tumor registry. Am J Surg Pathol. 2005; 29: 21-28.","DOI":"10.1097\/01.pas.0000147395.01229.06"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Salari B, Dehner LP. Juvenile and adult xanthogranuloma: A 30-year single-center experience and review of the disorder and its relationship to other histiocytoses. Ann Diagn Pathol. 2022; 58: 151940.","DOI":"10.1016\/j.anndiagpath.2022.151940"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Cambiaghi S, Restano L, Caputo R. Juvenile xanthogranuloma associated with neurofibromatosis 1: 14 patients without evidence of hematologic malignancies. Pediatr Dermatol. 2004; 21: 97-101.","DOI":"10.1111\/j.0736-8046.2004.21201.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Durham BH, Lopez Rodrigo E, Picarsic J et al.<\/i> Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms. Nat Med. 2019; 25: 1839-1842.","DOI":"10.1038\/s41591-019-0653-6"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 So N, Liu R, Hogeling M. Juvenile xanthogranulomas: Examining single, multiple, and extracutaneous presentations. Pediatr Dermatol. 2020; 37: 637-644.","DOI":"10.1111\/pde.14174"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Samuelov L, Kinori M, Chamlin SL et al.<\/i> Risk of intraocular and other extracutaneous involvement in patients with cutaneous juvenile xanthogranuloma. Pediatr Dermatol. 2018; 35: 329-335.","DOI":"10.1111\/pde.13437"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Maeda M, Morimoto A, Shioda Y et al.<\/i> Long-term outcomes of children with extracutaneous juvenile xanthogranulomas in Japan. Pediatr Blood Cancer. 2020; 67: e28381.","DOI":"10.1002\/pbc.28381"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Gru AA, Dehner LP. Cutaneous hematolymphoid and histiocytic proliferations in children. Pediatr Dev Pathol. 2018; 21: 208-251.","DOI":"10.1177\/1093526617750947"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Estrada-Veras JI, O\u2019Brien KJ, Boyd LC et al.<\/i> The clinical spectrum of Erdheim-Chester disease: an observational cohort study. Blood Adv. 2017; 1: 357-366.","DOI":"10.1182\/bloodadvances.2016001784"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Cohen-Aubart F, Emile JF, Carrat F et al.<\/i> Phenotypes and survival in Erdheim-Chester disease: Results from a 165-patient cohort. Am J Hematol. 2018; 93: E114-E117.","DOI":"10.1002\/ajh.25055"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D et al.<\/i> Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine (Baltimore). 1996; 75: 157-169.","DOI":"10.1097\/00005792-199605000-00005"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Papo M, Diamond EL, Cohen-Aubart F et al.<\/i> High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis. Blood. 2017; 130: 1007-1013.","DOI":"10.1182\/blood-2017-01-761718"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Ozkaya N, Rosenblum MK, Durham BH et al.<\/i> The histopathology of Erdheim-Chester disease: a comprehensive review of a molecularly characterized cohort. Mod Pathol. 2018; 31: 581-597.","DOI":"10.1038\/modpathol.2017.160"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Emile JF, Abla O, Fraitag S et al.<\/i> Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016; 127: 2672-2681.","DOI":"10.1182\/blood-2016-01-690636"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Garces S, Yin CC, Patel KP et al.<\/i> Focal Rosai-Dorfman disease coexisting with lymphoma in the same anatomic site: a localized histiocytic proliferation associated with MAPK\/ERK pathway activation. Mod Pathol. 2019; 32: 16-26.","DOI":"10.1038\/s41379-018-0152-1"},{"key":"18","unstructured":"18 Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol. 1990; 7: 19-73."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Garces S, Medeiros LJ, Patel KP et al.<\/i> Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease. Mod Pathol. 2017; 30: 1367-1377.","DOI":"10.1038\/modpathol.2017.55"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Abla O, Jacobsen E, Picarsic J et al.<\/i> Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood. 2018; 131: 2877-2890.","DOI":"10.1182\/blood-2018-03-839753"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Pulsoni A, Anghel G, Falcucci P et al.<\/i> Treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): report of a case and literature review. Am J Hematol. 2002; 69: 67-71.","DOI":"10.1002\/ajh.10008"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Brenn T, Calonje E, Granter SR et al.<\/i> Cutaneous rosai-dorfman disease is a distinct clinical entity. Am J Dermatopathol. 2002; 24: 385-391.","DOI":"10.1097\/00000372-200210000-00001"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Bruce-Brand C, Schneider JW, Schubert P. Rosai-Dorfman disease: an overview. J Clin Pathol. 2020; 73: 697-705.","DOI":"10.1136\/jclinpath-2020-206733"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Chan JK, Lamant L, Algar E et al.<\/i> ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy. Blood. 2008; 112: 2965-2968.","DOI":"10.1182\/blood-2008-03-147017"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Chang KTE, Tay AZE, Kuick CH et al.<\/i> ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion. Mod Pathol. 2019; 32: 598-608.","DOI":"10.1038\/s41379-018-0168-6"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Kemps PG, Picarsic J, Durham BH et al.<\/i> ALK-positive\u00a0histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition. Blood. 2022; 139: 256-280.","DOI":"10.1182\/blood.2021013338"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Tran TAN, Chang KTE, Kuick CH, Goh JY, Chang CC. Local ALK-positive histiocytosis with unusual morphology and novel TRIM33-ALK gene fusion. Int J Surg Pathol. 2021; 29: 543-549.","DOI":"10.1177\/1066896920976862"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Kashima J, Yoshida M, Jimbo K et al.<\/i> ALK-positive histiocytosis of the breast: A clinicopathologic study highlighting spindle cell histology. Am J Surg Pathol. 2021; 45: 347-355.","DOI":"10.1097\/PAS.0000000000001567"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Osako T, Kurisaki-Arakawa A, Dobashi A et al.<\/i> Distinct clinicopathologic features and possible pathogenesis of localized ALK-positive histiocytosis of the breast. Am J Surg Pathol. 2022; 46: 344-352.","DOI":"10.1097\/PAS.0000000000001794"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Takahashi E, Nakamura S. Histiocytic sarcoma : an updated literature review based on the 2008 WHO classification. J Clin Exp Hematop. 2013; 53: 1-8.","DOI":"10.3960\/jslrt.53.1"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Egan C, Lack J, Skarshaug S et al.<\/i> The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy. Mod Pathol. 2021; 34: 336-347.","DOI":"10.1038\/s41379-020-00673-x"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Chen W, Lau SK, Fong D et al.<\/i> High frequency of clonal immunoglobulin receptor gene rearrangements in sporadic histiocytic\/dendritic cell sarcomas. Am J Surg Pathol. 2009; 33: 863-873.","DOI":"10.1097\/PAS.0b013e31819287b8"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Shanmugam V, Griffin GK, Jacobsen ED et al.<\/i> Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma. Mod Pathol. 2019; 32: 830-843.","DOI":"10.1038\/s41379-018-0200-x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Massoth LR, Hung YP, Ferry JA et al.<\/i> Histiocytic and dendritic cell sarcomas of hematopoietic origin share targetable genomic alterations distinct from follicular dendritic cell sarcoma. Oncologist. 2021; 26: e1263-e1272.","DOI":"10.1002\/onco.13801"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Hornick JL, Jaffe ES, Fletcher CD. Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol. 2004; 28: 1133-1144.","DOI":"10.1097\/01.pas.0000131541.95394.23"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Vos JA, Abbondanzo SL, Barekman CL et al.<\/i> Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163. Mod Pathol. 2005; 18: 693-704.","DOI":"10.1038\/modpathol.3800346"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Kraus MD, Haley JC, Ruiz R et al.<\/i> \u201cJuvenile\u201d xanthogranuloma: an immunophenotypic study with a reappraisal of histogenesis. Am J Dermatopathol. 2001; 23: 104-111.","DOI":"10.1097\/00000372-200104000-00004"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Ungureanu IA, Cohen-Aubart F, H\u00e9ritier S et al.<\/i> PU.1 is a useful nuclear marker to distinguish between histiocytosis and histiocyte-rich tumours. Histopathology. 2023; 83: 320-325.","DOI":"10.1111\/his.14909"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Ravindran A, Goyal G, Go RS, Rech KL. Rosai-Dorfman disease displays a unique monocyte-macrophage phenotype characterized by expression of OCT2. Am J Surg Pathol. 2021; 45: 35-44.","DOI":"10.1097\/PAS.0000000000001617"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Nakamine H, Yamakawa M, Yoshino T et al.<\/i> Langerhans cell histiocytosis and langerhans cell sarcoma: Current understanding and differential diagnosis. J Clin Exp Hematop. 2016; 56: 109-118.","DOI":"10.3960\/jslrt.56.109"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Ohtake H, Yamakawa M. Interdigitating dendritic cell sarcoma and follicular dendritic cell sarcoma: histopathological findings for differential diagnosis. J Clin Exp Hematop. 2013; 53: 179-184.","DOI":"10.3960\/jslrt.53.179"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Facchetti F, Bertalot G, Grigolato PG. KP1 (CD 68) staining of malignant melanomas. Histopathology. 1991; 19: 141-145.","DOI":"10.1111\/j.1365-2559.1991.tb00004.x"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Shabo I, St\u00e5l O, Olsson H, Dor\u00e9 S, Svanvik J. Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival. Int J Cancer. 2008; 123: 780-786.","DOI":"10.1002\/ijc.23527"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Maniecki MB, Etzerodt A, Ulh\u00f8i BP et al.<\/i> Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells. Int J Cancer. 2012; 131: 2320-2331.","DOI":"10.1002\/ijc.27506"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Ma C, Horlad H, Ohnishi K et al.<\/i> CD163-positive cancer cells are potentially associated with high malignant potential in clear cell renal cell carcinoma. Med Mol Morphol. 2018; 51: 13-20.","DOI":"10.1007\/s00795-017-0165-8"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Matsubara E, Komohara Y, Shinchi Y et al.<\/i> CD163-positive cancer cells are a predictor of a worse clinical course in lung adenocarcinoma. Pathol Int. 2021; 71: 666-673.","DOI":"10.1111\/pin.13144"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Kanno H, Nishihara H, Wang L et al.<\/i> Expression of CD163 prevents apoptosis through the production of granulocyte colony-stimulating factor in meningioma. Neuro-oncol. 2013; 15: 853-864.","DOI":"10.1093\/neuonc\/not028"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Pileri SA, Grogan TM, Harris NL et al.<\/i> Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology. 2002; 41: 1-29.","DOI":"10.1046\/j.1365-2559.2002.01418.x"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Ritterhouse LL, Barletta JA. BRAF V600E mutation-specific antibody: A review. Semin Diagn Pathol. 2015; 32: 400-408.","DOI":"10.1053\/j.semdp.2015.02.010"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50 Syrykh C, Ysebaert L, P\u00e9ricart S et al.<\/i> ALK-positive histiocytosis associated with chronic lymphocytic leukaemia\/small lymphocytic lymphoma: a multitarget response under ibrutinib. Virchows Arch. 2021; 478: 779-783.","DOI":"10.1007\/s00428-020-02937-y"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51 Horna P, Shao H, Idrees A, Glass LF, Torres-Cabala CA. Indeterminate dendritic cell neoplasm of the skin: A 2-case report and review of the literature. J Cutan Pathol. 2017; 44: 958-963.","DOI":"10.1111\/cup.13017"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 Liu W, Liu HJ, Wang WY et al.<\/i> Multisystem ALK-positive histiocytosis: a multi-case study and literature review. Orphanet J Rare Dis. 2023; 18: 53.","DOI":"10.1186\/s13023-023-02649-x"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53 Chan AC, Serrano-Olmo J, Erlandson RA, Rosai J. Cytokeratin-positive malignant tumors with reticulum cell morphology: a subtype of fibroblastic reticulum cell neoplasm? Am J Surg Pathol. 2000; 24: 107-116.","DOI":"10.1097\/00000478-200001000-00013"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54 Bonometti A. The triptych of mixed histiocytosis: a systematic review of 105 cases and proposed clinical classification. Leuk Lymphoma. 2021; 62: 32-44.","DOI":"10.1080\/10428194.2020.1824070"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55 Yamada R, Miyata-Takata T, Tanaka R, Komohara Y, Takata K. Myeloid sarcoma incidentally found in lymph nodes dissected for advanced gastric cancer. J Clin Exp Hematop. 2023; 63: 139-142.","DOI":"10.3960\/jslrt.23013"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56 Alexiev BA, Wang W, Ning Y et al.<\/i> Myeloid sarcomas: a histologic, immunohistochemical, and cytogenetic study. Diagn Pathol. 2007; 2: 42.","DOI":"10.1186\/1746-1596-2-42"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57 Hung YP, Qian X. Histiocytic Sarcoma. Arch Pathol Lab Med. 2020; 144: 650-654.","DOI":"10.5858\/arpa.2018-0349-RS"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58 Audouin J, Comperat E, Le Tourneau A et al.<\/i> Myeloid sarcoma: clinical and morphologic criteria useful for diagnosis. Int J Surg Pathol. 2003; 11: 271-282.","DOI":"10.1177\/106689690301100404"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59 DeKoter RP, Singh H. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science. 2000; 288: 1439-1441.","DOI":"10.1126\/science.288.5470.1439"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60 Muirhead D, Stone MS, Syrbu SI. The utility of PU.1 as an immunohistochemical marker for histiocytic and dendritic lesions of the skin. Am J Dermatopathol. 2009; 31: 432-435.","DOI":"10.1097\/DAD.0b013e31818866a7"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61 Hung YP, Lovitch SB, Qian X. Histiocytic sarcoma: New insights into FNA cytomorphology and molecular characteristics. Cancer Cytopathol. 2017; 125: 604-614.","DOI":"10.1002\/cncy.21851"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62 McCune RC, Syrbu SI, Vasef MA. Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkin\u2019s and non-Hodgkin\u2019s lymphomas: a comparative study using high throughput tissue microarrays. Mod Pathol. 2006; 19: 1010-1018.","DOI":"10.1038\/modpathol.3800622"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63 Doyle LA, Fletcher CD. EMA positivity in epithelioid fibrous histiocytoma: a potential diagnostic pitfall. J Cutan Pathol. 2011; 38: 697-703.","DOI":"10.1111\/j.1600-0560.2011.01747.x"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64 Nishith N, Siddiqui SH, R, Raja SK et al.<\/i> Utility of morphologic assessment of bone marrow biopsy in diagnosis of lysosomal storage disorders. Indian J Pathol Microbiol. 2023; 66: 91-95.","DOI":"10.4103\/ijpm.ijpm_725_21"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65 Dunn P, Kuo MC, Sun CF. Pseudo-Gaucher cells in mycobacterial infection: a report of two cases. J Clin Pathol. 2005; 58: 1113-1114.","DOI":"10.1136\/jcp.2004.018176"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66 Menon MP, Evbuomwan MO, Rosai J, Jaffe ES, Pittaluga S. A subset of Rosai-Dorfman disease cases show increased IgG4-positive plasma cells: another red herring or a true association with IgG4-related disease? Histopathology. 2014; 64: 455-459.","DOI":"10.1111\/his.12274"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67 Wang L, Li W, Zhang S et al.<\/i> Rosai-Dorfman disease mimicking IgG4-related diseases: a single-center experience in China. Orphanet J Rare Dis. 2020; 15: 285.","DOI":"10.1186\/s13023-020-01567-6"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/64\/3\/64_24031\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T05:06:25Z","timestamp":1727499985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/64\/3\/64_24031\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.24031","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"24031"}}